About this episode

Discussion on novel investigational approaches for TROP2-directed antibody-drug conjugates in advanced breast cancer.

Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast Cancer

People in this episode

Guests: Javier Cortés, MD, PhD, Laura Huppert, MD

Topics covered

• TROP2-Directed ADCs
• Advanced Breast Cancer
• Investigational Approaches
• Oncology
• Haematology

Keywords

• TROP2
• ADCs
• breast cancer
• oncology
• investigational drugs

More episodes of PeerVoice Oncology & Haematology Audio

• Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME Initiative · June 9, 2026 · 21 min
• Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances Emerge · June 5, 2026 · 19 min

Explore listener stats, chart rankings, contacts and more on the PeerVoice Oncology & Haematology Audio podcast page.